Lupin receives USFDA approval for generic Suprep Bowel Prep Kit

28 Feb 2017 Evaluate

Lupin has received final approval for its Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces from the United States Food and Drug Administration (USFDA) to market a generic version of Braintree Laboratories’ Suprep Bowel Prep Kit. The company shall commence promoting the product shortly. Suprep Bowel Prep Kit had US sales of $207.2 million, as per IMS MAT December 2016. 

Lupin’s Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is the AA rated generic equivalent of Braintree Laboratories’ Suprep Bowel Prep Kit. Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is indicated for cleansing of the colon in preparation for colonoscopy in adults.

Lupin is a pharmaceutical company and is engaged in formulation of drugs and active pharmaceutical ingredients (APIs), generics, biotechnology, novel drug discovery and development, drug delivery systems and specialty pharmaceuticals.


Lupin Share Price

1607.15 22.90 (1.45%)
10-May-2024 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.35
Dr. Reddys Lab 5904.55
Cipla 1341.20
Zydus Lifesciences 983.20
Lupin 1607.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.